Indirubin-3'-monoxime is a potent inhibitor of GSK-3β (IC50=22 nM)1. Indirubin-3'-monoxime also inhibits CDK1 (p34cdc2; IC50=180 nM) and CDK5 (IC50=100 nM)1. Indirubin-3'-monoxime reversibly arrests asynchronous HBL-100 cells at G22. This compound induces apoptosis in the mammary carcinoma cell line MCF-7 (10 µM). Indirubin-3'-monoxime is an inhibitor of Cdk2, cyclin A, cyclin B, cyclin E and p35.
1. Leclerc, S., et al. 2001. J. Biol. Chem. 276: 251-260. PMID: 11013232
Soluble in DMSO (6 mg/ml), ethanol (4 mg/ml), DMF (~10 mg/ml), 1:5 DMSO:PBS (pH 7.2) (0.15 mg/ml), and methanol. Insoluble in water.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Download SDS (MSDS)
Certificate of Analysis
Adobe Acrobat Reader is required to reliably view, print and comment on PDF documents
bvseo_sdk, java_sdk, bvseo-3.2.0
CLOUD, getContent, 119ms
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
Lee JJ; et alLee JJ; et al. (PubMed ID: 25451564) determined that Indirubin-3'-monoxime inhibited collagen-induced platelet aggregation by suppressing phospholipase C 2 (PLC 2) phosphorylation, in rat carotid artery injury model. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn